摘要
目的观察胸腺肽片治疗慢性乙型肝炎的临床疗效。方法将60例慢性乙型肝炎患者随机分为治疗组和对照组,治疗组联用双虎清肝颗粒(12g/次,2次/d)和胸腺肽片(3次/d,40mg/次),而对照组单用双虎清肝颗粒(12g/次,2次/d),疗程均为3个月。分别随访6个月后观察两组临床症状、体征及ALT复常率(%)。结果治疗后两组ALT复常率(%)均有上升趋势,但治疗后9个月显示治疗组明显优于对照组(P<0.05)。结论胸腺肽片联合双虎清肝颗粒可以提高慢性乙型肝炎患者ALT复常率。
Objective To observe the clinical therapeutic elect of thymopeptide tablets in the treatment of chronic hepatitis B. Methods Patients were randomly divided into the study group and control group.The patients in the study group were treated with Shuanghuqinggan granule（12g,Bid）and thymopeptide tablets （40mg,Tid）,while patients in control group were treated with Shuanghuqinggan granule（12g,Bid）.Laboratory indicators of ALT normalization rate was respectively detected before and 3 months after the treatment,and 6 months after the follow-up. Results 9 months after the treatment laboratory indicators of ALT normalization rate was increasing in both group,which were more notable in study group diferent from those in control group （P〈0.05）. Conclusion Thymopeptide tablets plus Shuanghuqinggan granule were suitable for increasing ALT normalization rate.
出处
《中国现代医药杂志》
2009年第5期92-93,共2页
Modern Medicine Journal of China
关键词
肝炎
乙型
慢性
双虎清肝颗粒
胸腺肽片
Hepatitis B Chronic Shuanghuqinggan granule Thymopeptide tablets
